B-type natriuretic peptide for congestive heart failure

Journal of Clinical Ligand Assay

Volumn 25, Issue 2, 2002, Pages 155-159

  Wu, Alan H B ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

B type natriuretic peptide; Drug therapy; Echocardiography; Renin angiotensin aldosterone axis; Systolic and diastolic heart failure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; NESIRITIDE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

BLOOD LEVEL; CHROMATOGRAPHY; CONGESTIVE HEART FAILURE; CORRELATION FUNCTION; DEVICE; DIAGNOSTIC VALUE; DIASTOLE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; HEART DEATH; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FILLING PRESSURE; HUMAN; IMMUNOASSAY; MUSCLE STRETCHING; PATIENT MONITORING; PROTEIN SECRETION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; SEROLOGY; SYSTOLE;

EID: 0038647592     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Chavey WE, Blaum CS, Bleske BE, Van Harrison R, Kesterson S, Nicklas JM: Guideline for the management of heart failure caused by systolic dysfunction. Part I. Guideline development, etiology and diagnosis. Am Fam Physician 2001;64:769-774.
2. Weinberger HD: Diagnosis and treatment of diastolic heart failure. Hosp Practice 1999;34(3):115-126.
3. Kuritzky L: Heart failure 101. Hosp Practice 1998;33(12):96-101.
4. Mills RM, LeJemtel TH, Horton DP, Liang C, Lang R, Silver MA, Liu C, Chatterjee K: Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure. J Am Coll Cardiol 1999;34:155-162.
5. Mair J, Friedl W, Thomas S, Puschendorf B: Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest 1999;59(Suppl 230):132-142.
6. Matsuo H: Discovery of a natriuretic peptide family and their clinical application. Can J Physiol Pharmacol 2001;79:736-740.
7. Forssmann W, Meyer M, Forssmann K: The renal urodilatin system: clinical implications. Cardiovascul Res 2001;51:450-462.
8. Wieczorek SJ, Wu AHB, Christenson R, Rosano T, Hager D, Bailly K, Dahlen J, Chambers BS, Maisel A: Multi-center clinical evaluation of the Triage B-type natriuretic peptide (BNP) assay for the diagnosis of heart failure. Am Heart J 2002;144:834-839.
9. Hammerer-Lercher A, Neubauer E, Muller S, Pachinger O, Puschendorf B, Mair J: Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminial pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001;310:193-197.
10. Shimizu H, Aono K, Masuta K, Asada H, Misaki A, Teroaka H: Degradation of human brain natriuretic peptide (BNP) by contact activation of blood coagulation system. Clin Chim Acta 2001;305:181-186.
11. th ed., Little, Brown and Co., Boston, 1994, pp 253-259.
12. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA: Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrinol 1997;47:287-296.
13. Davis M, Espiner E, Richards G, Billings J, Town I, Drennan C, Richards M, Turner J, Yandel T: Plasma brain natriuretic peptide in assessment of acute dysponea. Lancet 1994;343:440-444.
14. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
15. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AHB, Clopton P, Steg PG, Westheim A, Wold Knudsen C, Perez A, Kazanegra R, Herrmann HC, McCollough PA, for the BNP Multinational Study Investigators: Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure: Preliminary results from the Breathing Not Properly (BNP) Multinational Study. N Engl J Med 2002;347:161-7.
16. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Wold Knudsen C, Storrow AB, Abraham WT, Lamba S, Wu AHB, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS, and for the BNP Multinational Study Investigators: B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: Analysis From Breathing Not Properly (BNP) Multinational Study. Circulation 2002;106:416-422.
17. Maisel AS, McCord J, Nowak RM, Hollendor JE, Duc P, Steg G, Omland T, Westheim A, Abraham WT, Storrow AB, McKay CA, Wu AH, McCollough PA: B-type natriuretic peptide in the emergency diagnosis of diastolic dysfunction heart failure. J Am Coll Cardiol 2002;39(suppl A):104A.
18. Remme WJ, Swedberg K: Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Eur Heart J 2001;22:1527-1560.
19. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall-Pedoe H, McMurray JJ, Dargie HJ: Brain natriuretic peptide concentration was effective for screening for LV systolic dysfunction. Lancet 1998;351:9-13.
20. deLemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH,Hall C, Cannon CP, Braunwald E: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-1021.
21. Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, Maisel A: A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study. J Cardiac Failure 2001;7:21-29.
22. Hara Y, Hamada M, Shigematsu Y, Suzuki M, Kodama K, Kuwahara T, Hashida H, Ikeda S, Ohtsuka T, Hiasa G, Hiwada K: Effect of beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor. Jpn Circ J 2000;64:365-369.
23. Yamamoto K, Burnett JC, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure - prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-516.
24. Choy AMJ, Darbar D, Lang CC, Pringle TH, McNeill GP, Kennedy NS, Struthers AD: Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical echocardiographic, and neurohoromal methods. Br Heart J 1994;72:16-22.